Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7395)
All Articles published online
|
Publishing Process of This Article
|
Nov 27, 2014 (publication date) through May 7, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | El-Garem H, Ammer A, Shehab H, Shaker O, Anwer M, El-Akel W, Omar H. Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma. World J Hepatol 2014; 6(11): 818-824 [PMID: 25429320 DOI: 10.4254/wjh.v6.i11.818] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v6/i11/818.htm |
| Number | Citing Articles |
| 1 |
Moustafa Nouh Elemeery, Ahmed Noah Badr, Marwa Anwar Mohamed, Doaa Ahmed Ghareeb. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients. World Journal of Gastroenterology 2017; 23(21): 3864-3875 doi: 10.3748/wjg.v23.i21.3864
|
| 2 |
Marta Afonso, Pedro Rodrigues, André Simão, Rui Castro. Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma. Journal of Clinical Medicine 2016; 5(3): 30 doi: 10.3390/jcm5030030
|
| 3 |
Fatma A. Fathy.Elmougy, Reham A. Mohamed, Mona M. Hassan, Suzan M. Elsheikh, Raghda N. Marzban, Fatma-elzahraa M. Ahmed, Rady E. Elaraby. Study of serum microRNA19a and microRNA223 as potential biomarkers for early diagnosis of hepatitis C virus-related hepatocellular carcinoma. Gene Reports 2019; 15: 100398 doi: 10.1016/j.genrep.2019.100398
|
| 4 |
Meng Meng, Rui Zhang, Ran Han, Yu Kong, Ruhua Wang, Lihua Hou. The polysaccharides from the Grifola frondosa fruiting body prevent lipopolysaccharide/d-galactosamine-induced acute liver injury via the miR-122-Nrf2/ARE pathways. Food & Function 2021; 12(5): 1973 doi: 10.1039/D0FO03327H
|
| 5 |
Meiyu Dai, Limin Li, Xue Qin. Clinical value of miRNA‑122 in the diagnosis and prognosis of various types of cancer. Oncology Letters 2019; doi: 10.3892/ol.2019.10024
|
| 6 |
Abdul Malik, Prajjalendra Barooah, Snigdha Saikia, Subhash Medhi, Simanta Kalita, Manash Jyoti Kalita, Partha Pratim Das, Kalpajit Dutta, Pooja Bharali, Manash Pratim Sarma, Preeti Sarma, Mallika Bhattacharyya, Premashis Kar, Bhabadev Goswami, Musaed Alkholief, Aws Alshamsan. Circulating MicroRNA-122 as a Potential Biomarker for Hepatitis C Virus Induced Hepatocellular Carcinoma. International Journal of Cancer Management 2022; 15(11) doi: 10.5812/ijcm-131221
|
| 7 |
Sirio Fiorino, Maria Letizia Bacchi-Reggiani, Michela Visani, Giorgia Acquaviva, Adele Fornelli, Michele Masetti, Andrea Tura, Fabio Grizzi, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Luca Di Tommaso, Arrigo Bondi, Sergio Sabbatani, Andrea Domanico, Carlo Fabbri, Paolo Leandri, Annalisa Pession, Elio Jovine, Dario de Biase. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma. World Journal of Gastroenterology 2016; 22(15): 3907-3936 doi: 10.3748/wjg.v22.i15.3907
|
| 8 |
Montaser Bellah Yasser, Mahmoud Abdellatif, Esraa Emad, Afnan Jafer, Samar Ahmed, Lobna Nageb, Hanan Abdelshafy, Amany Mohamed Al-Anany, Mohamed Ali Ezz Al-Arab, Abdullah Ahmed Gibriel. Circulatory miR-221 & miR-542 expression profiles as potential molecular biomarkers in Hepatitis C Virus mediated liver cirrhosis and hepatocellular carcinoma. Virus Research 2021; 296: 198341 doi: 10.1016/j.virusres.2021.198341
|
| 9 |
Ashraf Y. Elfert, Amel Salem, Amr M. Abdelhamid, Ahmad Salama, Doaa A. Sourour, Olfat Shaker, Mofida Keshk. Implication of miR-122, miR-483, and miR-335 Expression Levels as Potential Signatures in HCV-Related Hepatocellular Carcinoma (HCC) in Egyptian Patients. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.864839
|
| 10 |
Tsutomu Kawaguchi, Shuhei Komatsu, Daisuke Ichikawa, Masahiro Tsujiura, Hiroki Takeshita, Shoji Hirajima, Mahito Miyamae, Wataru Okajima, Takuma Ohashi, Taisuke Imamura, Jun Kiuchi, Hirotaka Konishi, Atsushi Shiozaki, Kazuma Okamoto, Eigo Otsuji. Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers. International Journal of Molecular Sciences 2016; 17(9): 1459 doi: 10.3390/ijms17091459
|
| 11 |
Sijia Shen, Yuxin Lin, Xuye Yuan, Li Shen, Jiajia Chen, Luonan Chen, Lei Qin, Bairong Shen. Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison. Scientific Reports 2016; 6(1) doi: 10.1038/srep38311
|
| 12 |
Farzaneh Moshiri, Alessandro Salvi, Laura Gramantieri, Angelo Sangiovanni, Paola Guerriero, Giuseppina De Petro, Cristian Bassi, Laura Lupini, Arash Sattari, Douglas Cheung, Dario Veneziano, Giovanni Nigita, Ram C. Shankaraiah, Nazario Portolani, Paolo Carcoforo, Francesca Fornari, Luigi Bolondi, Antonio Frassoldati, Silvia Sabbioni, Massimo Colombo, Carlo M. Croce, Massimo Negrini. Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma. Oncotarget 2018; 9(20): 15350 doi: 10.18632/oncotarget.24601
|
| 13 |
Yicheng Huang, Yingsha Chen, Sheng Tu, Jiajie Zhang, Yunqing Qiu, Wei Yu. Diagnostic accuracy of circulating microRNAs for hepatitis C virus-associated hepatocellular carcinoma: a systematic review and meta-analysis. BMC Infectious Diseases 2022; 22(1) doi: 10.1186/s12879-022-07292-8
|
| 14 |
Michela Visani, Giorgia Acquaviva, Sirio Fiorino, Maria Letizia Bacchi Reggiani, Michele Masetti, Enrico Franceschi, Adele Fornelli, Elio Jovine, Carlo Fabbri, Alba A Brandes, Giovanni Tallini, Annalisa Pession, Dario de Biase. Contribution of microRNA analysis to characterisation of pancreatic lesions: a review. Journal of Clinical Pathology 2015; 68(11): 859 doi: 10.1136/jclinpath-2015-203246
|
| 15 |
Tarek K. Motawi, Olfat G. Shaker, Shohda A. El-Maraghy, Mahmoud A. Senousy, Anand S Mehta. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients. PLOS ONE 2015; 10(9): e0137706 doi: 10.1371/journal.pone.0137706
|
| 16 |
Emad K. Ahmed, Shaimaa A. Fahmy, Heba Effat, Abdel Hady Abdel Wahab. Circulating miR-210 and miR-1246 as potential biomarkers for differentiating hepatocellular carcinoma from metastatic tumors in the liver. Journal of Medical Biochemistry 2019; 38(2): 109 doi: 10.2478/jomb-2018-0010
|
| 17 |
Amin Ullah, Xiaojie Yu, Margarete Odenthal, Sonja Meemboor, Bashir Ahmad, Irshad ur Rehman, Jamshaid Ahmad, Qurban Ali, Tariq Nadeem, Gianfranco D. Alpini. Circulating microRNA-122 in HCV cirrhotic patients with high frequency of genotype 3. PLOS ONE 2022; 17(5): e0268526 doi: 10.1371/journal.pone.0268526
|
| 18 |
|
| 19 |
Hala M. Demerdash, Hend M. Hussien, Ehab Hassouna, Emad A. Arida. Detection of MicroRNA in Hepatic Cirrhosis and Hepatocellular Carcinoma in Hepatitis C Genotype-4 in Egyptian Patients. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/1806069
|
| 20 |
Amanda Abdel-Al, Eman El-Ahwany, Mona Zoheiry, Marwa Hassan, Amged Ouf, Hoda Abu-Taleb, Ali Abdel Rahim, Mohamed Darwish El-Talkawy, Suher Zada. miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patients. Virus Research 2018; 253: 135 doi: 10.1016/j.virusres.2018.06.007
|
| 21 |
Areeg M. Dabbish, Hana M. Abdelzaher, Moustafa Abohawya, Samir Shamma, Yosra H. Mahmoud, Amr Maged, Mohamed Manaa, Mohamed Hassany, Firas Kobeissy, Omid Bazgir, Hassan El-Fawal, Hassan M. E. Azzazy, Anwar Abdelnaser. Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical Validation. Cancers 2022; 14(13): 3036 doi: 10.3390/cancers14133036
|
| 22 |
Osama M. Ahmed, Hanaa I. Fahim, Eman E. Mohamed, Adel Abdel-Moneim. Protective effects of Persea americana fruit and seed extracts against chemically induced liver cancer in rats by enhancing their antioxidant, anti-inflammatory, and apoptotic activities. Environmental Science and Pollution Research 2022; 29(29): 43858 doi: 10.1007/s11356-022-18902-y
|
| 23 |
Reem Abdel Hamid Harfoush, Marwa Ahmed Meheissen, Reham Abel Haleem Abo Elwafa, Doaa Ahmed Elwazzan. The Role of Circulating MicroRNAs as Markers of Disease Progression in Hepatitis C Virus Infected Egyptian Patients. Advances in Microbiology 2016; 6(04): 320 doi: 10.4236/aim.2016.64031
|
| 24 |
Wataru Okajima, Shuhei Komatsu, Daisuke Ichikawa, Mahito Miyamae, Takuma Ohashi, Taisuke Imamura, Jun Kiuchi, Keiji Nishibeppu, Tomohiro Arita, Hirotaka Konishi, Atsushi Shiozaki, Ryo Morimura, Hisashi Ikoma, Kazuma Okamoto, Eigo Otsuji. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids. World Journal of Gastroenterology 2017; 23(31): 5650-5668 doi: 10.3748/wjg.v23.i31.5650
|
| 25 |
Noha Ahmed El Boghdady, Olfat Gamil Shaker. Role of Serum miR-181b, Proinflammatory Cytokine, and Adhesion Molecules in Behçet's Disease. Journal of Interferon & Cytokine Research 2019; 39(6): 347 doi: 10.1089/jir.2018.0116
|
| 26 |
Shan Huang, Da Zhou, Yu‐Xuan Li, Zhi‐Yong Ming, Ke‐Zhi Li, Guo‐Bin Wu, Chuang Chen, Yin‐Nong Zhao. Retracted: In vivo and in vitro effects of microRNA‐221 on hepatocellular carcinoma development and progression through the JAK–STAT3 signaling pathway by targeting SOCS3. Journal of Cellular Physiology 2019; 234(4): 3500 doi: 10.1002/jcp.26863
|
| 27 |
Cheng Peng, Yanshuo Ye, Zhanpeng Wang, Lianyue Guan, Suriguga Bao, Bo Li, Wei Li. Circulating microRNAs for the diagnosis of hepatocellular carcinoma. Digestive and Liver Disease 2019; 51(5): 621 doi: 10.1016/j.dld.2018.12.011
|
| 28 |
Heba K. Nabih. The Significance of HCV Viral Load in the Incidence of HCC: a Correlation Between Mir-122 and CCL2. Journal of Gastrointestinal Cancer 2020; 51(2): 412 doi: 10.1007/s12029-019-00281-2
|
| 29 |
Xiao-Fei Zhao, Ning Li, Dong-Dong Lin, Li-Bo Sun. Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/5353695
|
| 30 |
Huaixiang Zhou, Qiuran Xu, Chao Ni, Song Ye, Xiaowu Xu, Xiaoge Hu, Jiahong Jiang, Yeting Hong, Dongsheng Huang, Liu Yang. Prospects of Noncoding RNAs in Hepatocellular Carcinoma. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/6579436
|
| 31 |
Keisaku Sato, Fanyin Meng, Shannon Glaser, Gianfranco Alpini. Corrigendum to “Exosomes in liver pathology”. Journal of Hepatology 2016; 65(3): 655 doi: 10.1016/j.jhep.2016.06.016
|
| 32 |
Elodie Miquelestorena‐Standley, Anne Tallet, Christine Collin, Eric Piver, Anne De Muret, Ephrem Salamé, Pascal Bourlier, Thibault Kervarrec, Serge Guyétant, Jean‐Christophe Pagès. Interest of variations in microRNA‐152 and ‐122 in a series of hepatocellular carcinomas related to hepatitis C virus infection. Hepatology Research 2018; 48(7): 566 doi: 10.1111/hepr.12915
|
| 33 |
Xiao-yu Wei, Jing Ding, Wen-guang Tian, Yi-Chuan Yu. MicroRNA-122 as a diagnostic biomarker for hepatocellular carcinoma related to hepatitis C virus: a meta-analysis and systematic review. Journal of International Medical Research 2020; 48(8): 030006052094163 doi: 10.1177/0300060520941634
|
| 34 |
O. G. Shaker, M. A. Senousy. Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus‐associated chronic liver disease patients. Journal of Viral Hepatitis 2017; 24(8): 636 doi: 10.1111/jvh.12696
|
| 35 |
Khalda S. Amr, Hanan Abd Elmawgoud Atia, Rehab Abd Elazeem Elbnhawy, Wafaa M. Ezzat. Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma. Genes & Diseases 2017; 4(4): 215 doi: 10.1016/j.gendis.2017.10.003
|
| 36 |
Junqi You, Haoming Xia, Ziyue Huang, Risheng He, Xudong Zhao, Jiali Chen, Sidi Liu, Yi Xu, Yunfu Cui. Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1204715
|
| 37 |
Hamdy E. Abouzeid Ali, Rehab Abdel Hameed, Heba Effat, Emad K. Ahmed, Azza A. Atef, Sabry K. Sharawi, Mohamed Ali, Zakaria Y. Abd Elmageed, Abdel Hady Abdel Wahab. Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2017; 41(4): e51 doi: 10.1016/j.clinre.2017.06.004
|
| 38 |
Javad Moayedi, Tayebeh Hashempour, Zahra Musavi, Ehsan Arefian, Mahmood Naderi, Mohamad Reza Heidari, Behzad Dehghani, Zahra Hasanshahi, Shahin Merat. Evaluation of miR-122 Serum Level and IFN-λ3 Genotypes in Patients with Chronic HCV and HCV-Infected Liver Transplant Candidate. MicroRNA 2021; 10(1): 58 doi: 10.2174/2211536609666201217101414
|
| 39 |
Amira S. Abo ElAtta, Yasser B. M. Ali, Iman H. Bassyouni, Roba M. Talaat. Upregulation of miR-221/222 expression in rheumatoid arthritis (RA) patients: correlation with disease activity. Clinical and Experimental Medicine 2019; 19(1): 47 doi: 10.1007/s10238-018-0524-3
|
| 40 |
Tarek K. Motawi, Dahlia A. Mohsen, Shohda A. El-Maraghy, Mona A. Kortam. MicroRNA-21, microRNA-181a and microRNA-196a as potential biomarkers in adult Egyptian patients with systemic lupus erythematosus. Chemico-Biological Interactions 2016; 260: 110 doi: 10.1016/j.cbi.2016.11.001
|
| 41 |
Assessment of serum level of MiRNAs before and after treatment with sofosbuvir in Egyptian patients with chronic HCV infection. Meta Gene 2018; 18: 93 doi: 10.1016/j.mgene.2018.08.005
|
| 42 |
Marwa A. Ali, Olfat G. Shaker, Eman M. Ezzat, Hanaa M. Eid, Doaa Y. Ali, Essam A. Hassan, Dalia H. Elsayed, Eman R. Abozaid, Omayma O. Abdelaleem. Serum lncRNAs, NBAT‐1, and FOXCUT signature in hepatocellular carcinoma developed on top of chronic hepatitis C. Molecular Carcinogenesis 2023; 62(3): 319 doi: 10.1002/mc.23488
|
| 43 |
Mohamed El‐Hefny, Shawky Fouad, Tarek Hussein, Rehab Abdel‐Hameed, Heba Effat, Haitham Mohamed, Abdel Hady Abdel Wahab. Circulating microRNAs as predictive biomarkers for liver disease progression of chronic hepatitis C (genotype‐4) Egyptian patients. Journal of Medical Virology 2019; 91(1): 93 doi: 10.1002/jmv.25294
|
| 44 |
Hui-Chun Li, Chee-Hing Yang, Shih-Yen Lo. Roles of microRNAs in Hepatitis C Virus Replication and Pathogenesis. Viruses 2022; 14(8): 1776 doi: 10.3390/v14081776
|
| 45 |
Ying-Hsiu Su, Amy K. Kim, Surbhi Jain. Liquid biopsies for hepatocellular carcinoma. Translational Research 2018; 201: 84 doi: 10.1016/j.trsl.2018.07.001
|
| 46 |
Yujia Fang, Dong Yan, Lixin Wang, Jie Zhang, Qingfang He. Circulating microRNAs (miR‐16, miR‐22, miR‐122) expression and early diagnosis of hepatocellular carcinoma. Journal of Clinical Laboratory Analysis 2022; 36(7) doi: 10.1002/jcla.24541
|
| 47 |
Amany A. Saleh, Shimaa E. Soliman, Mona Salah El-din Habib, Suzy F. Gohar, Ghada S. Abo-Zeid. Potential value of circulatory microRNA122 gene expression as a prognostic and metastatic prediction marker for breast cancer. Molecular Biology Reports 2019; 46(3): 2809 doi: 10.1007/s11033-019-04727-5
|
| 48 |
Maryam Keshavarzi, Saba Sorayayi, Mohammad Jafar Rezaei, Mohsen Mohammadi, Amir Ghaderi, Ayoob Rostamzadeh, Aria Masoudifar, Hamed Mirzaei. MicroRNAs‐Based Imaging Techniques in Cancer Diagnosis and Therapy. Journal of Cellular Biochemistry 2017; 118(12): 4121 doi: 10.1002/jcb.26012
|
| 49 |
Tarek K. Motawi, Mohamed R. Mohamed, Nancy N. Shahin, Mohamed A.M. Ali, May A. Azzam. Time-course expression profile and diagnostic potential of a miRNA panel in exosomes and total serum in acute liver injury. The International Journal of Biochemistry & Cell Biology 2018; 100: 11 doi: 10.1016/j.biocel.2018.05.002
|
| 50 |
Song He, Xiao-Wu Hu, Dong Wang, Ling-Fei Han, De-chun Zhang, Cheng Wei. Accuracy of microRNAs for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology 2016; 40(4): 405 doi: 10.1016/j.clinre.2016.02.001
|
| 51 |
Song He, De-Chun Zhang, Cheng Wei. MicroRNAs as biomarkers for hepatocellular carcinoma diagnosis and prognosis. Clinics and Research in Hepatology and Gastroenterology 2015; 39(4): 426 doi: 10.1016/j.clinre.2015.01.006
|
| 52 |
Olfat Shaker, Maha Alhelf, George Morcos, Aisha Elsharkawy. miRNA-101-1 and miRNA-221 expressions and their polymorphisms as biomarkers for early diagnosis of hepatocellular carcinoma. Infection, Genetics and Evolution 2017; 51: 173 doi: 10.1016/j.meegid.2017.03.030
|
| 53 |
Jinghang Xu, Ping An, Cheryl A. Winkler, Yanyan Yu. Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01271
|
| 54 |
Abdel-Rahman Nabawy Zekri, Amira Salah El-Din Youssef, Eman Desouky El-Desouky, Ola Sayed Ahmed, Mai M. Lotfy, Auhood Abdel-Monem Nassar, Abeer A. Bahnassey. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Tumor Biology 2016; 37(9): 12273 doi: 10.1007/s13277-016-5097-8
|
| 55 |
Jian Li, Sun Qiyu, Tiezheng Wang, Boxun Jin, Ning Li. Improving the Detection of Hepatocellular Carcinoma using serum AFP expression in combination with GPC3 and micro-RNA miR-122 expression. Open Life Sciences 2019; 14(1): 53 doi: 10.1515/biol-2019-0007
|